$14.28
0.140.99%
al cierre: -
$14.28
0.000.00%
After hour: Oct 24, 4:00 PM EDT
Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
Theravance Biopharma informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
nov 11
Estimación de BPA
$-0.080
Estimación de ingresos trimestrales
$19.77M
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
$77.20M
Analice el historial de beneficios de Theravance Biopharma utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
TBPH | Theravance Biopharma | -$0.06 | -$0.08 | — | — | $16.87M | $19.77M | — | — | 11/11/2025 | |
TBPH | Theravance Biopharma | -$0.13 | -$0.17 | -$0.08 | 52.94% | $14.26M | $22.44M | $26.20M | 16.75% | 08/12/2025 | |
TBPH | Theravance Biopharma | -$0.09 | -$0.09 | -$0.27 | -200.00% | $14.50M | $28.07M | $15.39M | -45.18% | 05/08/2025 | |
TBPH | Theravance Biopharma | -$0.17 | -$0.08 | -$0.05 | 37.50% | $17.57M | $17.09M | $18.75M | 9.74% | 02/26/2025 | |
TBPH | Theravance Biopharma | -$0.17 | -$0.23 | -$0.06 | 73.91% | $15.69M | $15.34M | $16.87M | 9.96% | 11/12/2024 | |
TBPH | Theravance Biopharma | -$0.13 | -$0.21 | -$0.13 | 38.10% | $13.75M | $15.45M | $14.26M | -7.73% | 08/05/2024 | |
TBPH | Theravance Biopharma | -$0.24 | -$0.25 | -$0.09 | 64.00% | $10.42M | $13.96M | $14.50M | 3.89% | 05/13/2024 | |
TBPH | Theravance Biopharma | -$0.15 | -$0.15 | -$0.17 | -13.33% | $14.65M | $17.68M | $17.57M | -0.65% | 02/26/2024 | |
TBPH | Theravance Biopharma | -$0.21 | -$0.21 | -$0.17 | 19.05% | $12.45M | $15.00M | $15.69M | 4.62% | 11/07/2023 | |
TBPH | Theravance Biopharma | -$0.04 | -$0.16 | -$0.13 | 18.75% | $11.05M | $15.24M | $13.75M | -9.78% | 08/07/2023 | |
TBPH | Theravance Biopharma | -$0.33 | -$0.26 | -$0.24 | 7.69% | $13.20M | $13.84M | $10.42M | -24.73% | 05/08/2023 | |
TBPH | Theravance Biopharma | -$0.18 | -$0.17 | -$0.21 | -23.53% | $14.95M | $15.73M | $14.65M | -6.87% | 02/27/2023 | |
TBPH | Theravance Biopharma | -$0.46 | -$0.18 | -$0.21 | -16.67% | $13.19M | $12.05M | $12.45M | 3.33% | 11/07/2022 | |
TBPH | Theravance Biopharma | -$0.80 | -$0.03 | -$0.04 | -33.33% | $12.91M | $12.41M | $11.05M | -10.96% | 08/04/2022 | |
TBPH | Theravance Biopharma | -$1.24 | -$0.11 | -$0.22 | -100.00% | $14.26M | $14.48M | $13.20M | -8.87% | 05/05/2022 | |
TBPH | Theravance Biopharma | -$0.92 | -$0.33 | -$0.18 | 45.45% | $18.73M | $13.48M | $14.95M | 10.87% | 02/23/2022 | |
TBPH | Theravance Biopharma | -$1.16 | -$0.55 | -$0.46 | 16.36% | $18.26M | $14.69M | $13.19M | -10.18% | 11/03/2021 | |
TBPH | Theravance Biopharma | -$1.00 | -$1.01 | -$0.80 | 20.79% | $15.01M | $15.41M | $12.91M | -16.20% | 08/03/2021 | |
TBPH | Theravance Biopharma | -$1.14 | -$1.05 | -$1.24 | -18.10% | $19.86M | $17.27M | $14.26M | -17.45% | 05/04/2021 | |
TBPH | Theravance Biopharma | -$1.17 | -$1.02 | -$0.92 | 9.80% | $29.50M | $20.85M | $18.73M | -10.17% | 02/23/2021 | |
TBPH | Theravance Biopharma | -$1.05 | -$0.97 | -$1.16 | -19.59% | $12.43M | $18.58M | $18.26M | -1.74% | 11/05/2020 |
Theravance Biopharma (TBPH) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-12 | $-0.08 | $-0.17 | 52.9 % |
| Q1 | 2025-05-08 | $-0.27 | $-0.09 | -200.0 % |
| Q4 | 2025-02-26 | $-0.05 | $-0.08 | 37.5 % |
| Q3 | 2024-11-12 | $-0.06 | $-0.23 | 73.9 % |
Theravance Biopharma (TBPH) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-12 | $26.20M | $22.44M | 16.8 % |
| Q1 | 2025-05-08 | $15.39M | $28.07M | -45.2 % |
| Q4 | 2025-02-26 | $18.75M | $17.09M | 9.74 % |
| Q3 | 2024-11-12 | $16.87M | $15.34M | 9.96 % |
PREGUNTAS FRECUENTES
¿Cuándo Theravance Biopharma (NASDAQ:TBPH) publicará los resultados?
Está previsto que Theravance Biopharma (TBPH) presente resultados el noviembre 11, 2025. Los últimos resultados se publicaron el agosto 12, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de Theravance Biopharma (NASDAQ:TBPH)?
El BPA real fue de $-0.08, que superó la estimación de $-0.17.
¿Cuáles fueron los ingresos de Theravance Biopharma (NASDAQ:TBPH)?
Los ingresos reales fueron $26.2M, que superó la estimación de $22.4M.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.